These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 21191649)

  • 1. P53 genotype as a determinant of ER expression and tamoxifen response in the MMTV-Wnt-1 model of mammary carcinogenesis.
    Fuchs-Young R; Shirley SH; Lambertz I; Colby JK; Tian J; Johnston D; Gimenez-Conti IB; Donehower LA; Conti CJ; Hursting SD
    Breast Cancer Res Treat; 2011 Nov; 130(2):399-408. PubMed ID: 21191649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional regulation of estrogen receptor-alpha by p53 in human breast cancer cells.
    Shirley SH; Rundhaug JE; Tian J; Cullinan-Ammann N; Lambertz I; Conti CJ; Fuchs-Young R
    Cancer Res; 2009 Apr; 69(8):3405-14. PubMed ID: 19351845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reprogramming of the estrogen responsive transcriptome contributes to tamoxifen-dependent protection against tumorigenesis in the p53 null mammary epithelial cells.
    Palaniappan M; Edwards D; Creighton CJ; Medina D; Conneely OM
    PLoS One; 2018; 13(3):e0194913. PubMed ID: 29590203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen receptor positivity in mammary tumors of Wnt-1 transgenic mice is influenced by collaborating oncogenic mutations.
    Zhang X; Podsypanina K; Huang S; Mohsin SK; Chamness GC; Hatsell S; Cowin P; Schiff R; Li Y
    Oncogene; 2005 Jun; 24(26):4220-31. PubMed ID: 15824740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The gain of function of p53 cancer mutant in promoting mammary tumorigenesis.
    Lu X; Liu DP; Xu Y
    Oncogene; 2013 Jun; 32(23):2900-6. PubMed ID: 22824795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamoxifen inhibition of estrogen receptor-alpha-negative mouse mammary tumorigenesis.
    Medina D; Kittrell FS; Hill J; Shepard A; Thordarson G; Brown P
    Cancer Res; 2005 Apr; 65(8):3493-6. PubMed ID: 15833886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus.
    Zelazny E; Li B; Anagnostopoulos AM; Coleman A; Perkins AS
    Exp Mol Pathol; 2001 Jun; 70(3):183-93. PubMed ID: 11417997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combination of tamoxifen and the rexinoid LG100268 prevents ER-positive and ER-negative mammary tumors in p53-null mammary gland mice.
    Mazumdar A; Medina D; Kittrell FS; Zhang Y; Hill JL; Edwards DE; Bissonnette RP; Brown PH
    Cancer Prev Res (Phila); 2012 Oct; 5(10):1195-202. PubMed ID: 22926341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mouse mammary tumor virus-Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-alpha.
    Bocchinfuso WP; Hively WP; Couse JF; Varmus HE; Korach KS
    Cancer Res; 1999 Apr; 59(8):1869-76. PubMed ID: 10213494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Neu-induced mammary carcinogenesis in transgenic mice expressing ERΔ3, a dominant negative estrogen receptor α variant.
    Davis VL; Shaikh F; Gallagher KM; Villegas M; Rea SL; Cline JM; Hughes CL
    Horm Cancer; 2012 Dec; 3(5-6):227-39. PubMed ID: 22968785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The BCL9-2 proto-oncogene governs estrogen receptor alpha expression in breast tumorigenesis.
    Zatula N; Wiese M; Bunzendahl J; Birchmeier W; Perske C; Bleckmann A; Brembeck FH
    Oncotarget; 2014 Aug; 5(16):6770-87. PubMed ID: 25149534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53-mediated senescence impairs the apoptotic response to chemotherapy and clinical outcome in breast cancer.
    Jackson JG; Pant V; Li Q; Chang LL; Quintás-Cardama A; Garza D; Tavana O; Yang P; Manshouri T; Li Y; El-Naggar AK; Lozano G
    Cancer Cell; 2012 Jun; 21(6):793-806. PubMed ID: 22698404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acceleration of mouse mammary tumor virus-induced murine mammary tumorigenesis by a p53 172H transgene: influence of FVB background on tumor latency and identification of novel sites of proviral insertion.
    Chatterjee G; Rosner A; Han Y; Zelazny ET; Li B; Cardiff RD; Perkins AS
    Am J Pathol; 2002 Dec; 161(6):2241-53. PubMed ID: 12466138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the AIB1 oncogene through mammalian target of rapamycin inhibition in the mammary gland.
    Torres-Arzayus MI; Yuan J; DellaGatta JL; Lane H; Kung AL; Brown M
    Cancer Res; 2006 Dec; 66(23):11381-8. PubMed ID: 17145884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Responsiveness of
    Alothman SJ; Wang W; Goerlitz DS; Islam M; Zhong X; Kishore A; Azhar RI; Kallakury BV; Furth PA
    Cancer Prev Res (Phila); 2017 Apr; 10(4):244-254. PubMed ID: 28283467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.
    Cicchini M; Chakrabarti R; Kongara S; Price S; Nahar R; Lozy F; Zhong H; Vazquez A; Kang Y; Karantza V
    Autophagy; 2014; 10(11):2036-52. PubMed ID: 25483966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 in breast cancer subtypes and new insights into response to chemotherapy.
    Bertheau P; Lehmann-Che J; Varna M; Dumay A; Poirot B; Porcher R; Turpin E; Plassa LF; de Roquancourt A; Bourstyn E; de Cremoux P; Janin A; Giacchetti S; Espié M; de Thé H
    Breast; 2013 Aug; 22 Suppl 2():S27-9. PubMed ID: 24074787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GPNMB augments Wnt-1 mediated breast tumor initiation and growth by enhancing PI3K/AKT/mTOR pathway signaling and β-catenin activity.
    Maric G; Annis MG; MacDonald PA; Russo C; Perkins D; Siwak DR; Mills GB; Siegel PM
    Oncogene; 2019 Jun; 38(26):5294-5307. PubMed ID: 30914799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.
    McCormack SJ; Weaver Z; Deming S; Natarajan G; Torri J; Johnson MD; Liyanage M; Ried T; Dickson RB
    Oncogene; 1998 May; 16(21):2755-66. PubMed ID: 9652742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor escape in a Wnt1-dependent mouse breast cancer model is enabled by p19Arf/p53 pathway lesions but not p16 Ink4a loss.
    Debies MT; Gestl SA; Mathers JL; Mikse OR; Leonard TL; Moody SE; Chodosh LA; Cardiff RD; Gunther EJ
    J Clin Invest; 2008 Jan; 118(1):51-63. PubMed ID: 18060046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.